The study seeks to evaluate the safety and efficacy of the molecule FNP-223, 1 a novel therapy intended to slow the progression of Progressive Supranuclear Palsy (PSP). 1,2 The PROSPER study is a ...
Some results have been hidden because they may be inaccessible to you